Title:
DRUG FOR TREATING OR PREVENTING MACROPHAGE-MEDIATED DISEASES AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/083176
Kind Code:
A1
Abstract:
Disclosed are the uses of amniotic fluid in the preparation of a drug for treating and/or preventing macrophage-mediated diseases, a drug for treating and/or preventing type M1 macrophage-mediated diseases, a drug for treating and/or preventing type M2 macrophage-mediated diseases, a preparation for treating and/or preventing TLR4/NF-κB signaling pathway-mediated diseases, a preparation for inhibiting the number of type M1 macrophages and increasing the proportion of type M2 macrophages or a preparation for promoting the conversion of type M1 macrophages to type M2 macrophages. The amniotic fluid is from eggs at an embryo age of 5-12 days, or eggs from poultry other than chickens at the development stage corresponding to the development stage of the above-mentioned eggs at the embryo age; or embryos of rodent animals at the embryo age of 8-14 days, or embryos of non-human mammals other than rodent animals at the development stage corresponding to the development stage of the above-mentioned rodent animals at the embryo age of 8-14 days.
Inventors:
QIAN JIN (CN)
Application Number:
PCT/CN2023/125342
Publication Date:
April 25, 2024
Filing Date:
October 19, 2023
Export Citation:
Assignee:
ANHUI HYGEIANCELLS BIOMEDICAL CO LTD (CN)
International Classes:
A61K35/57; A61K35/50; A61K45/08; A61P1/00; A61P3/00; A61P9/00; A61P11/00; A61P13/00; A61P17/00; A61P19/00; A61P25/00; A61P27/00; A61P31/00; A61P35/00; A61P37/00; A61P43/00
Attorney, Agent or Firm:
SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC (CN)
Download PDF: